Petros Pharmaceuticals, Inc. [PTPI] - General Assignment for the Benefit of Creditors
On September 30, 2026, Petros Pharmaceuticals, Inc. assigned all its assets to PT Liquidation, LLC for the benefit of creditors, marking a liquidation event as the company ceased operations and is unable to continue as a going concern.
Why this matters
Petros Pharmaceuticals, Inc., a Delaware-incorporated company operating in the pharmaceutical preparations industry, has ceased operations and entered into a liquidation process. On September 30, 2026, the company assigned all its assets to PT Liquidation, LLC for the benefit of creditors, effectively marking the end of its business activities. This decision follows the resignation of key board members and executives, including the Executive Chairman and Chief Accounting Officer, on the same date. The assignment for the benefit of creditors (ABC) indicates that Petros Pharmaceuticals was unable to continue as a going concern, likely due to financial distress, although specific reasons such as leverage or liquidity issues were not detailed in the filing.